Santhera Pharmaceuticals Holding AG
SPHDF News Today: Stay Updated with the Latest Santhera Pharmaceuticals Holding AG News in Real Time
Find SPHDF news now at Meyka AI. Stay informed with the latest Santhera Pharmaceuticals Holding AG stocks updates, including price news, market analysis, and expert insights.
8395.HK Stock Surges 46% as Qi-House Holdings Leads High Volume Trading
ZXZN Qi-House Holdings (8395.HK) jumps 46% on 4.6M volume. Furniture retailer shows strong momentum on HKSE with HK$0.46 price.
MGRM Directors File Initial Ownership Forms, April 30, 2026
Monogram Orthopaedics directors Gray Colleen and Van Kirk Richard Lee Jr file initial ownership disclosures for stock options totaling 5,000 shares.
AMRX Earnings Preview: Amneal Pharmaceuticals Q1 2026 May 1
Amneal Pharmaceuticals (AMRX) reports Q1 2026 earnings May 1. Analysts expect $0.1691 EPS and $719.66M revenue. What to watch.
AMRX Earnings Preview: May 1 Report, $0.17 EPS Expected
Amneal Pharmaceuticals earnings preview for May 1, 2026. Analysts expect $0.1691 EPS and $719.66M revenue. Historical performance analysis inside.
0252.HK Stock Flat at HK$1.60 on April 30, 2026
Southeast Asia Properties & Finance Limited (0252.HK) trades at HK$1.60 with flat performance. Meyka AI rates the stock C+ with a Hold recommendation.
CGNX Stock Down 0.4% in Pre-Market as Cognex Nears Q1 Earnings
CGNX stock trades at $53.52 in pre-market, down 0.4% ahead of Q1 2026 earnings announcement on May 6. Analyst consensus remains bullish.
POR Earnings Preview: Portland General Electric May 1 Report
Portland General Electric earnings preview for May 1, 2026. EPS estimate $0.77, revenue $953M. Analyst expectations and key metrics.
CEG Maintained at Outperform by Scotiabank April 2026
Scotiabank maintained Constellation Energy (CEG) at Outperform with price target lowered to $441 from $481 on April 29, 2026.
PRAX Earnings Preview: May 1 Report Signals Continued Losses
Praxis Precision Medicines reports May 1 earnings with -$3.58 EPS estimate and $100K revenue forecast amid clinical-stage biotech challenges.